None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male and female patients with androgenic alopecia 2. Age of 20-65 years, provide written informed consent and comply with the study requirements 3. Norwood-Hamilton grades I-V 4. Active hair loss within last 12 months 5. No clinically significant disease or abnormal laboratory results at the time of screening visit 6. Patient has adequate abdominal or other subcutaneous adipose tissue accessible by syringe-based lipoharvest 7. For women of child-bearing potential: negative pregnancy test at screening visit
Exclusion criteria
Exclusion criteria: 1. Patients with inflammation, infection, malignancy, allegoric disease, autoimmune disease, pregnancy, diabetes and on current anticoagulant therapy. 2. Subject who has previously failed or has been deemed nonresponsive to a previous experimental hair loss treatment, prior surgery in the treatment area and subject who has a sensitive, irritated, or abraded scalp area 3. Clinically significant medical or psychiatric illness currently or within 30 days of study screening as determined by the investigator 4. Any disease or condition (medical or surgical) that in the opinion of the investigator, might compromise hematologic, cardiovascular, pulmonary, renal, gastrointestinal, hepatic, or central nervous system function; or any condition that would place the subject at increased risk
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Alopecia grede, Hair density, Hair thickness | — |
Secondary
| Measure | Time frame |
|---|---|
| scalp status, keratin of scalp, scalp sensitivity, scalp sebum, hair pore status, and cuticle status | — |
Countries
Korea, Republic of
Contacts
TOP Cell Plastic Surgery